OFFICER INDEMNIFICATION AGREEMENTOfficer Indemnification Agreement • February 2nd, 2022 • Kiromic Biopharma, Inc. • Biological products, (no disgnostic substances) • Delaware
This INDEMNIFICATION AGREEMENT (“Agreement”) is made as of January 27, 2022 by and between Kiromic Biopharma, Inc., a Delaware corporation (the “Company”), and Pietro Bersani (“Indemnitee”). This Agreement supersedes and replaces any and all previous agreements between the Company and Indemnitee covering the subject matter of this Agreement, except this Agreement does not affect any prior agreements regarding the subject matter of this Agreement entered into in connection with Indemnitee’s role as a member of the Company’s Board of Directors (collectively, “Director Indemnification Agreements”), which shall remain in full force and effect pursuant to their terms.
CONFIDENTIAL INFORMATION, INVENTIONS, NON-SOLICITATION AND NON-COMPETITION AGREEMENTSolicitation and Non-Competition Agreement • February 2nd, 2022 • Kiromic Biopharma, Inc. • Biological products, (no disgnostic substances) • Texas
In consideration of my employment by Kiromic Biopharma Inc., and its subsidiaries, parents, affiliates, successors and assigns (together, “Kiromic” or the “Company”) and the compensation now and later paid to me, I hereby enter into this Employee Confidential Information, Inventions, Non Solicitation and Non-Competition Agreement (the “Agreement”) and agree as follows:
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 2nd, 2022 • Kiromic Biopharma, Inc. • Biological products, (no disgnostic substances) • Texas
THIS EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”), is effective as of January 27, 2022 (the “Effective Date”) by and between Kiromic Biopharma, Inc., a Delaware corporation (the “Company”), and Mr. Pietro Bersani (the “Executive”). Throughout the remainder of the Agreement, the Company and Executive may be individually referred to as a “Party” or collectively referred to as “the Parties.”
